Constructing Capabilities: Holistic Infrastructure Development In Decentralized Manufacturing
Source: Germfree
In this panel, Sean Bartholomew (Biopharma Applications Engineer, Germfree) and Grayson Heller (COO, cGMPnow) discuss the considerations for decentralized cell therapy manufacturing. The key points include the importance of designing identical and cloned processes, focusing on a copy-paste model for multiple locations.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Germfree
This website uses cookies to ensure you get the best experience on our website. Learn more